RecruitingPhase 3NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Sponsor: Merck Sharp & Dohme LLC
Post Falls, ID · +53 more sites
1 recruiting parkinson's disease studies with a site in Post Falls, ID.
All trials in Post Falls, ID · All Parkinson's Disease trials
Sponsor: Merck Sharp & Dohme LLC
Post Falls, ID · +53 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.